Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001875825 | SCV002309238 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2023-08-04 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV002261297 | SCV002541791 | uncertain significance | not provided | 2021-05-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436736 | SCV002745884 | uncertain significance | Cardiovascular phenotype | 2021-09-07 | criteria provided, single submitter | clinical testing | The p.P955L variant (also known as c.2864C>T), located in coding exon 19 of the APOB gene, results from a C to T substitution at nucleotide position 2864. The proline at codon 955 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV001875825 | SCV002784010 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2021-08-13 | criteria provided, single submitter | clinical testing |